The production of doubled haploids has become a necessary tool in advanced plant breeding institutes and commercial companies for breeding many crop species. However, the development of new, more efficient and cheaper large scale production protocols has meant that doubled haploids are also recently being applied in less advanced breeding programmes. This Manual was prepared to stimulate the wider use of this technology for speeding and opening up new breeding possibilities for many crops including some woody tree species. Since the construction of genetic maps using molecular markers requires the development of segregating doubled haploid populations in numerous crop species, we hope that this Manual will also help molecular biologists in establishing such mapping populations. For many years, both the Food and Agriculture Organization of the United Nations (FAO) and the International Atomic Energy Agency (IAEA) have supported and coordinated research that focuses on development of more efficient doubled haploid production methods and their applications in breeding of new varieties and basic research through their Plant Breeding and Genetics Section of the Joint F AO/IAEA Division of Nuclear Techniques in Food and Agriculture. The first F AO/IAEA scientific network (Coordinated Research Programme - CRP) dealing with doubled haploids was initiated by the Plant Breeding and Genetics Section in 1986.
The series Advances in Industrial Control aims to report and encourage technology transfer in control engineering. The rapid development of control technology impacts all areas of the control discipline. New theory, new controllers, actuators, sensors, new industrial processes, computer methods, new applications, new philosophies..., new challenges. Much of this development work resides in industrial reports, feasibility study papers and the reports of advanced collaborative projects. The series offers an opportunity for researchers to present an extended exposition of such new work in all aspects of industrial control for wider and rapid dissemination. The environmental aspects of all of our society's activities are extremely important if the countryside; the sea and wildernesses are to be fully enjoyed by future generations. Urban waste in all its manifestations presents a particularly difficult disposal problem, which must be tackled conscientiously to prevent long lasting damage to the environment. Technological solutions should be seen as part of the available options. In this monograph, the authors M. R. Katebi, M. A. Johnson and J. Wilkie seek to introduce a comprehensive technological framework to the particular measurement and control problems of wastewater processing plants. Of course the disposal of urban sewage is a long-standing process but past solutions have used options (disposal at sea) which are no longer acceptable. Thus to meet new effluent regulations it is necessary to develop a new technological paradigm based on process control methods, and this is what the authors attempt to provide.
Transgenic Plants: A Production System for Industrial and Pharmaceutical Proteins provides a detailed guide to the principles and practice of using transgenic plants as a system for the production of heterologous proteins. It is unique in that it covers the complete process of heterologous protein production in plants, from the initial transformation of the plant, through to transcription, transgene stability and finally the downstreaming processing events for protein purification. Written by an international team of industrialists and academics, this book describes:<br> * the fundamental issues associated with expressing heterologous proteins in plants;<br> * a number of detailed examples of the successful small-and large-scale production of proteins;<br> * the essentials of patenting; and<br> * the commercial exploitation.<br> Transgenic Plants: A Production System for Industrial and Pharmaceutical Proteins will be of interest to plant biotechnologists, molecular biologists and protein biochemists in the biotechnology and pharmaceutical industries.